ImmunArray raised €9.1M in a Series B round in Jul 2016. The company is based in Rehovot, Israel. Investors in the round: Exigent Capital. Data as of 7 Aug 2026.
Reported in EUR — no conversion. €9.1M
Confidence is the weaker of amount-FX and source evidence (the cascade rule). See methodology.
This is the company's only recorded round.
